|
C8ORF44 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.63640000000154E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.064020E-03 |
| Normal-vs-Stage2 |
1.250460E-02 |
| Normal-vs-Stage3 |
3.171000E-01 |
| Normal-vs-Stage4 |
1.661390E-01 |
| Stage1-vs-Stage2 |
1.516780E-01 |
| Stage1-vs-Stage3 |
2.196300E-02 |
| Stage1-vs-Stage4 |
5.418400E-01 |
| Stage2-vs-Stage3 |
3.909600E-02 |
| Stage2-vs-Stage4 |
9.998400E-01 |
| Stage3-vs-Stage4 |
2.549000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.17769999999651E-05 |
| Normal-vs-AfricanAmerican |
8.216700E-03 |
| Normal-vs-Asian |
5.412400E-01 |
| Caucasian-vs-AfricanAmerican |
4.460400E-01 |
| Caucasian-vs-Asian |
3.201600E-01 |
| AfricanAmerican-vs-Asian |
4.904200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.598540E-04 |
| Normal-vs-Female |
8.569200E-04 |
| Male-vs-Female |
8.048400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.411800E-02 |
| Normal-vs-Extreme_Weight |
1.921530E-03 |
| Normal-vs-Obese |
8.038300E-04 |
| Normal-vs-Extreme_Obese |
3.218600E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.482600E-01 |
| Normal_Weight-vs-Obese |
5.297200E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.151800E-01 |
| Extreme_Weight-vs-Obese |
6.448600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.685000E-01 |
| Obese-vs-Extreme_Obese |
5.004400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.547670E-02 |
| Normal-vs-Age(41-60Yrs) |
2.16419999999884E-05 |
| Normal-vs-Age(61-80Yrs) |
8.436000E-04 |
| Normal-vs-Age(81-100Yrs) |
7.409600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.491400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.530800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.148400E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.779610E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.902790E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.793690E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.67069999957148E-07 |
| Normal-VS-Type2 PRCC |
5.605000E-01 |
| Normal-VS-KIRP CIMP |
1.611990E-02 |
| Normal-VS-Unclassified PRCC |
7.823300E-03 |
| Type1 PRCC-VS-Type2 PRCC |
3.62149999999506E-06 |
| Type1 PRCC-VS-KIRP CIMP |
5.955800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.348200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.261420E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.760180E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
9.539000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.425700E-02 |
| Normal-vs-N1 |
2.871500E-02 |
| Normal-vs-N2 |
5.786600E-01 |
| N0-vs-N1 |
2.117200E-01 |
| N0-vs-N2 |
7.963800E-01 |
| N1-vs-N2 |
4.847800E-01 |
|
|
